Furthermore, thromboxane was elevated in genetic and dietary mice models of obesity and diabetes, while thromboxane depletion enhanced insulin sensitivity, glucose homeostasis, and CTRP9 secretion (Lei et al., 2015; Han et al., 2018). This evidence concerns the gene C1QTNF9 and obesity due to melanocortin 4 receptor deficiency.